Cefpimizole (AC-1370), a new cephem antibiotic, was studied clinically in the field of
obstetrics and gynecology, and the following results were obtained. AC-1370 was …

Fundamental and clinical studies on cefpimizole (AC-1370), a new cephem antibiotic, were
performed and the following results were obtained: Concentration of AC-1370 was …

The findings from recent fundamental and clinical studies of the efficacy of cefpimizole (AC-
1370) in obstetrics and gynecology are reported in this paper. The AC-1370 concentrations …

Cefpimizole (AC-1370) concentrations in the pelvic dead space exudate were determined in
patients under-going curative resection of carcinoma of the uterine cervix to study the …

Materials and Methods The efficacy and safety of AC-1370 were evaluated in 11 patients at
the Kurume University Hospital. Eight patients received 1g of AC-1370 2 times per day and 3 …

We made fundamental and clinical studies of a new cephalosporin derivative cefpimizole
(AC-1370), and found the following. In 7 patients treated with AC-1370 for the fundamental …

Fundamental and clinical studies on cefpimizole (AC-1370), a new cephalosporin derivative,
in the field of obstetrics and gynecology have been investigated, and the following results …

Ceftriaxone (Ro 13-9904, CTRX), a newly developed third-generation cephem antibiotic,
reportedly has an antibacterial spectrum of wide-range and shows a much greater activity …

Cefpimizole (AC-1370), a new cephalosporin antibiotic, was evaluated for its distribution in
uterine tissue, penetration into retroperitoneal exudate and therapeutical effects on some …

The findings from fundamental and clinical studies on cefpimizole (AC-1370) in the
treatment of infections in obstetrics and gynecology are reported. We investigated the …